ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2025
Homoharringtonine combined with venetoclax and azacitidine: An effective and safe regimen for patients with refractory/relapsed acute myeloid leukemia.
Yiling Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.